160 related articles for article (PubMed ID: 15028317)
21. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
22. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
23. The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency.
Gulcelik MA; Gulcelik NE; Dinc S; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2006 Jul; 94(1):35-9. PubMed ID: 16788941
[TBL] [Abstract][Full Text] [Related]
24. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
25. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
26. Selective surgery and adjuvant therapy based on risk classifications of well-differentiated thyroid cancer.
Cross S; Wei JP; Kim S; Brams DM
J Surg Oncol; 2006 Dec; 94(8):678-82. PubMed ID: 17131414
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
28. Predicting outcome and directing therapy for papillary thyroid carcinoma.
Kim S; Wei JP; Braveman JM; Brams DM
Arch Surg; 2004 Apr; 139(4):390-4; discussion 393-4. PubMed ID: 15078706
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
30. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
31. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
[TBL] [Abstract][Full Text] [Related]
32. Familial non-medullary thyroid cancer: a matched-case control study.
Maxwell EL; Hall FT; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
[TBL] [Abstract][Full Text] [Related]
33. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
Zaydfudim V; Feurer ID; Griffin MR; Phay JE
Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
[TBL] [Abstract][Full Text] [Related]
34. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
Saadi H; Kleidermacher P; Esselstyn C
Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
[TBL] [Abstract][Full Text] [Related]
35. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
37. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
38. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in well-differentiated thyroid carcinoma.
Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
[TBL] [Abstract][Full Text] [Related]
40. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
